Cyclone Alfred is set to move onshore in the coming days and rain is likely to impact Wednesday’s Sunshine Coast meeting.

Phase 2 TRANQUILITY trial in patients with elevated high-sensitivity C-reactive protein and chronic kidney disease over-enrolled to 143 total ...

Q4 2024 Earnings Call Transcript March 12, 2025 Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.15 ...

Dogwood Therapeutics, Inc. (Nasdaq: DWTX) ("Dogwood" or the "Company"), a development-stage biopharmaceutical company focused on advancing first-in-class, ...

NF1 is a debilitating rare genetic disorder that causes tumours to form along nerves ... A Potential Breakthrough for NF1 Patients “This trial represents an important step in determining ...

Monogram Technologies Inc. ( NASDAQ: MGRM) Q4 2024 Earnings Conference Call March 11, 2025 4:30 PM ET Larry Holub - Investor Relations Benjamin Sexson - Chief Executive Officer Noel Knape - Chief ...

Good morning, and welcome to Agenus Inc.'s fourth-quarter and year-end 2024 earnings conference call. Currently, all ...

They don’t feel it was served during the lengthy federal murder trial for the man who brutally murdered Eric ... seeks to ...

Building on success across its three clinical programs, Avidity is leading in rare neuromuscular diseases with a strong balance sheet to execute on a transformational ...

The author argues that the judiciary is crucial for maintaining the balance of power and ensuring due process. This week marks the ninth year we’ve had some form ... set for trial for the ...

One powerlifter academic may have found a way to build lifelong, full-body strength and stability in a very old and rare source.

Q4 2024 Earnings Call Transcript February 27, 2025Ironwood Pharmaceuticals, Inc. misses on earnings expectations.